ABVC BioPharma (ABVC) Competitors $0.66 -0.03 (-4.35%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ABVC vs. DARE, ELEV, SRZN, LUMO, LTRN, CELU, BLRX, MIRA, LIAN, and ACSTShould you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Daré Bioscience (DARE), Elevation Oncology (ELEV), Surrozen (SRZN), Lumos Pharma (LUMO), Lantern Pharma (LTRN), Celularity (CELU), BioLineRx (BLRX), MIRA Pharmaceuticals (MIRA), LianBio (LIAN), and Acasti Pharma (ACST). These companies are all part of the "pharmaceutical products" industry. ABVC BioPharma vs. Daré Bioscience Elevation Oncology Surrozen Lumos Pharma Lantern Pharma Celularity BioLineRx MIRA Pharmaceuticals LianBio Acasti Pharma ABVC BioPharma (NASDAQ:ABVC) and Daré Bioscience (NASDAQ:DARE) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, community ranking, media sentiment, institutional ownership and valuation. Does the media favor ABVC or DARE? In the previous week, Daré Bioscience's average media sentiment score of 0.92 beat ABVC BioPharma's score of 0.00 indicating that Daré Bioscience is being referred to more favorably in the news media. Company Overall Sentiment ABVC BioPharma Neutral Daré Bioscience Positive Which has stronger earnings & valuation, ABVC or DARE? ABVC BioPharma has higher earnings, but lower revenue than Daré Bioscience. Daré Bioscience is trading at a lower price-to-earnings ratio than ABVC BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioABVC BioPharma$136.40K60.11-$10.52M-$1.66-0.40Daré Bioscience$2.81M12.66-$30.16M-$1.12-3.71 Which has more risk and volatility, ABVC or DARE? ABVC BioPharma has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Daré Bioscience has a beta of 1.39, suggesting that its share price is 39% more volatile than the S&P 500. Do institutionals & insiders have more ownership in ABVC or DARE? 11.4% of ABVC BioPharma shares are owned by institutional investors. Comparatively, 6.7% of Daré Bioscience shares are owned by institutional investors. 11.9% of ABVC BioPharma shares are owned by company insiders. Comparatively, 4.0% of Daré Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in ABVC or DARE? Daré Bioscience received 355 more outperform votes than ABVC BioPharma when rated by MarketBeat users. CompanyUnderperformOutperformABVC BioPharmaN/AN/ADaré BioscienceOutperform Votes35573.20% Underperform Votes13026.80% Is ABVC or DARE more profitable? Daré Bioscience has a net margin of -253.65% compared to ABVC BioPharma's net margin of -8,363.97%. Daré Bioscience's return on equity of 0.00% beat ABVC BioPharma's return on equity.Company Net Margins Return on Equity Return on Assets ABVC BioPharma-8,363.97% -139.97% -75.61% Daré Bioscience -253.65%N/A -34.72% Do analysts recommend ABVC or DARE? Daré Bioscience has a consensus price target of $24.00, suggesting a potential upside of 476.92%. Given Daré Bioscience's higher probable upside, analysts clearly believe Daré Bioscience is more favorable than ABVC BioPharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ABVC BioPharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ADaré Bioscience 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryDaré Bioscience beats ABVC BioPharma on 10 of the 15 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get ABVC BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABVC vs. The Competition Export to ExcelMetricABVC BioPharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.20M$7.03B$5.40B$8.53BDividend YieldN/A7.96%5.13%4.14%P/E Ratio-0.409.93115.5615.18Price / Sales60.11381.421,484.3492.77Price / CashN/A47.3439.6634.07Price / Book0.655.324.665.02Net Income-$10.52M$153.56M$119.06M$225.46M7 Day Performance-4.64%0.11%0.80%0.37%1 Month Performance9.07%15.22%5.65%3.57%1 Year Performance-45.00%41.14%36.76%29.44% ABVC BioPharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABVCABVC BioPharmaN/A$0.66-4.3%N/A-40.0%$8.20M$136,396.00-0.4030Gap UpDAREDaré Bioscience1.5998 of 5 stars$4.23+6.8%$24.00+467.4%-15.4%$35.62M$2.84M-3.7730ELEVElevation Oncology1.956 of 5 stars$0.60+1.2%$7.80+1,200.0%+23.2%$35.46MN/A-0.7140Upcoming EarningsSRZNSurrozen2.0512 of 5 stars$11.00+15.8%N/A+113.9%$35.27M$12.50M0.0042Gap UpHigh Trading VolumeLUMOLumos Pharma3.2483 of 5 stars$4.34-0.7%$8.63+98.7%+21.4%$35.26M$1.49M-0.9830Upcoming EarningsLTRNLantern Pharma0.9061 of 5 stars$3.26-6.6%N/A+25.5%$35.09MN/A-1.9820News CoveragePositive NewsGap DownCELUCelularity0.068 of 5 stars$1.58-6.5%N/A-33.1%$34.74M$33.52M0.00220Gap UpBLRXBioLineRx2.2028 of 5 stars$0.43-1.3%$21.00+4,796.2%-72.2%$34.29M$17.05M-0.9540Analyst ForecastNews CoverageGap DownMIRAMIRA Pharmaceuticals3.2198 of 5 stars$2.20+27.2%$14.00+536.4%+25.8%$32.52MN/A-3.242High Trading VolumeLIANLianBio1.2118 of 5 stars$0.30+7.2%$3.50+1,070.6%-92.9%$32.31MN/A-0.37110Gap UpACSTAcasti Pharma2.6154 of 5 stars$3.37-0.9%$10.00+196.7%+39.8%$31.68MN/A-2.9632 Related Companies and Tools Related Companies Daré Bioscience Competitors Elevation Oncology Competitors Surrozen Competitors Lumos Pharma Competitors Lantern Pharma Competitors Celularity Competitors BioLineRx Competitors MIRA Pharmaceuticals Competitors LianBio Competitors Acasti Pharma Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ABVC) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABVC BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ABVC BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
